71 patents
Page 4 of 4
Utility
Use of Cannabidiol In the Treatment of Tuberous Sclerosis Complex
1 Jul 20
The present invention relates to the use of cannabidiol (CBD) for the treatment of tumours associated with Tuberous Sclerosis Complex (TSC).
Benjamin WHALLEY, William HIND, Royston GRAY, Michael BAZELOT, Ines De SILVA SERRA, Claire WILLIAMS, Andrew TEE
Filed: 20 Jun 18
Utility
Pharmaceutical Compositions for the Treatment of Disease And/or Symptoms In Arthritis
1 Jul 20
The invention relates to the use of a combination of cannabinoids for the treatment of pain, inflammation and/or disease modification in arthritis.
PHILIP ROBSON, Geoffrey Guy
Filed: 5 Sep 19
Utility
Use of Cannabinoids In the Treatment of Epilepsy
10 Jun 20
The present disclosure relates to the use of cannabidiol (CBD) for the reduction of total convulsive seizure frequency in the treatment of “treatment-resistant epilepsy” (TRE).
Geoffrey GUY, Stephen WRIGHT, Alice MEAD, Orrin DEVINSKY
Filed: 13 Feb 20
Utility
Use of cannabinoids in the treatment of mental disorders
18 May 20
This invention relates to the use of CBD to treat mental disorders.
Philip Robson, Geoffrey Guy, Stephen Wright, Emma Cheetham, Dominic Schiller
Filed: 7 Sep 16
Utility
Use of Cannabinoids In the Treatment of Epilepsy
6 May 20
The present invention relates in the use of cannabidiol (CBD) in the treatment of Sturge Weber syndrome.
Geoffrey GUY, Stephen WRIGHT, Alice MEAD, Anne COMI
Filed: 7 Jan 20
Utility
Anti-tumoural Effects of Cannabinoid Combinations
6 May 20
The invention relates to the use of a combination of cannabinoids, particularly tetrahydrocannabinol (THC) and cannabidiol (CBD), in the manufacture of a medicament for use in the treatment of cancer.
Guillermo VELASCO DIEZ, Manuel GUZMAN PASTOR, Mar LORENTE, Sofia TORRES, Fatima RODRIGUEZ
Filed: 6 Jun 19
Utility
Pharmaceutical Composition Comprising the Phytocannabinoids Cannabidivarin (CBDV) and Cannabidiol (CBD)
8 Apr 20
This invention relates to a pharmaceutical composition comprising or consisting essentially of the phytocannabinoids cannabidivarin (CBDV) and cannabidiol (CBD).
Benjamin Whalley, Claire Williams, Gary Stephens, Thomas Hill
Filed: 9 Dec 19
Utility
Pharmaceutical Formulation
1 Apr 20
The invention relates to pharmaceutical formulations, and more particularly to formulations containing cannabinoids for administration via a pump action spray.
BRIAN ANTHONY WHITTLE
Filed: 2 Dec 19
Utility
Use of cannabinoids in the treatment of epilepsy
30 Mar 20
The present disclosure relates to the use of cannabidiol (CBD) for the reduction of total convulsive seizure frequency in the treatment of “treatment-resistant epilepsy” (TRE).
Geoffrey Guy, Stephen Wright, Alice Mead, Orrin Devinsky
Filed: 8 Apr 18
Utility
Use of cannabinoids in the treatment of epilepsy
9 Mar 20
The present invention relates to the use of cannabidiol (CBD) in the treatment of Sturge Weber syndrome.
Geoffrey Guy, Stephen Wright, Alice Mead, Anne Comi
Filed: 27 Mar 17
Utility
Use of Cannabinoids In the Treatment of Epilepsy
4 Mar 20
The present disclosure relates to the use of cannabidiol (CBD) for the treatment of atonic seizures.
Geoffrey Guy, Stephen Wright, Alice Mead, Orrin Devinsky
Filed: 7 Nov 19